000 01455 a2200433 4500
005 20250513223410.0
264 0 _c20001130
008 200011s 0 0 eng d
022 _a0090-8258
024 7 _a10.1006/gyno.2000.5943
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBulten, J
245 0 0 _aProliferation in "atypical" atrophic pap smears.
_h[electronic resource]
260 _bGynecologic oncology
_cNov 2000
300 _a225-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies, Monoclonal
650 0 4 _aAtrophy
_xdrug therapy
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCervix Uteri
_xdrug effects
650 0 4 _aDecision Trees
650 0 4 _aDiagnosis, Differential
650 0 4 _aEpithelium
_xdrug effects
650 0 4 _aEstriol
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aKi-67 Antigen
_ximmunology
650 0 4 _aPostmenopause
_xphysiology
650 0 4 _aRetrospective Studies
650 0 4 _aUterine Cervical Neoplasms
_xdrug therapy
650 0 4 _aUterine Cervical Dysplasia
_xdrug therapy
700 1 _ade Wilde, P C
700 1 _aBoonstra, H
700 1 _aGemmink, J H
700 1 _aHanselaar, A G
773 0 _tGynecologic oncology
_gvol. 79
_gno. 2
_gp. 225-9
856 4 0 _uhttps://doi.org/10.1006/gyno.2000.5943
_zAvailable from publisher's website
999 _c11006164
_d11006164